Novo Informatics

Delhi, India Founded: 2011 • Age: 15 yrs
In silico computational drug design services are offered.
Annual revenue $17,191 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Novo Informatics

Novo Informatics is a company based in Delhi (India) founded in 2011 by Bhavin Mukund Mehta. Novo Informatics operates in a competitive market with competitors including Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.

  • Headquarter Delhi, India
  • Founders Bhavin Mukund Mehta
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Novo Informatics Private Limited
  • Date of Incorporation 08 Apr, 2011
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $17.19 K (USD)
    0
    as on Mar 31, 2017
  • Net Profit
    -$9.65 K (USD)
    0
    as on Mar 31, 2017
  • EBITDA
    -$13.08 K (USD)
    0
    as on Mar 31, 2017
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Novo Informatics

Premium access

Detailed funding history for Novo Informatics

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Novo Informatics

Investments
Premium access

Investment portfolio details for Novo Informatics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Novo Informatics

Premium access

Detailed financials for Novo Informatics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Novo Informatics Comparisons

Novo Informatics Primary company
Description
In silico computational drug design services are offered.
Location
Delhi, India
Founded Year
2011
Annual Revenue
$17.19 K (USD)
Net Profit
-$9.65 K (USD)
EBITDA
-$13.08 K (USD)
Employees
Not available
Premium access

Peer comparison for Novo Informatics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Novo Informatics

Novo Informatics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cyrus Biotechnology, Vividion Therapeutics, Seer, Biognosys and ProteinSimple, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Cloud-based protein-modeling software is developed for drug discovery.
Locked Locked Locked
Developing novel drugs based on a proteome-wide ligand and target discovery platform
Locked Locked Locked
Proteomics platform developed for early cancer and neurological disease detection.
Locked Locked Locked
Proteomics services are delivered via discovery and targeted platforms.
Locked Locked Locked
Provider tools to help researchers with protein analysis
Locked Locked Locked
Small molecule oncology therapeutics are developed for cancer treatment.
Premium access

Detailed competitors of Novo Informatics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Novo Informatics

Premium access

Complete news archive for Novo Informatics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novo Informatics

Novo Informatics was founded in 2011.

Novo Informatics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Annual revenue of Novo Informatics is $17.19K as on Mar 31, 2017.

Founded in 2011 and based in Delhi, India, Novo Informatics operates in the bioinformatics sector. Services for computational drug design are provided through proprietary platforms hosted on the SCFBio facility at IIT Delhi. These include Proteonov for protein structure annotation and Drugonov for processes from target selection to hit identification. Full drug discovery support is available, alongside the Inventus software for in-silico research methodologies in drug discovery.

Novo Informatics's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Biognosys.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available